 | • レポートコード：QAF27643 • 出版社/出版日：QYResearch / 2021年4月8日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の皮膚科薬市場について種類別（外用、経口、注射）、用途別（乾癬、皮膚感染症、にきび、皮膚炎、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・皮膚科薬市場の概要 ・世界の主要地域別皮膚科薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の皮膚科薬市場規模2016-2021：種類別（外用、経口、注射） ・世界の皮膚科薬市場予測2012-2027：種類別（外用、経口、注射） ・世界の皮膚科薬市場規模2016-2021：用途別（乾癬、皮膚感染症、にきび、皮膚炎、その他） ・世界の皮膚科薬市場予測2012-2027：用途別（乾癬、皮膚感染症、にきび、皮膚炎、その他） ・皮膚科薬のアメリカ市場規模と予測2016-2021 ・皮膚科薬のヨーロッパ市場規模と予測2016-2021 ・皮膚科薬の中国市場規模と予測2016-2021 ・皮膚科薬の日本市場規模と予測2016-2021 ・皮膚科薬の東南アジア市場規模と予測2016-2021 ・皮膚科薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AbbVie、Johnson & Johnson、Bayer、Galderma、Bristol-Myers Squibb、Novartis、Pfizer、Merz Pharma、Valeant、LEO Pharma、GlaxoSmithKline） ・皮膚科薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・皮膚科薬の市場動向・機会・課題 ・調査の結論 |
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%.
Market Analysis and Insights: Global Dermatology Drug Market
The global Dermatology Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Dermatology Drug Scope and Market Size
The global Dermatology Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermatology Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
External Use
Oral
Injection
Segment by Application
Psoriasis
Skin Infections
Acne
Dermatitis
Others
The Dermatology Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Dermatology Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
1 Dermatology Drug Market Overview
1.1 Dermatology Drug Product Scope
1.2 Dermatology Drug Segment by Type
1.2.1 Global Dermatology Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 External Use
1.2.3 Oral
1.2.4 Injection
1.3 Dermatology Drug Segment by Application
1.3.1 Global Dermatology Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Others
1.4 Dermatology Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Dermatology Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Dermatology Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Dermatology Drug Price Trends (2016-2027)
2 Dermatology Drug Estimates and Forecasts by Region
2.1 Global Dermatology Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Dermatology Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Dermatology Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Dermatology Drug Revenue Market Share by Region (2016-2021)
2.3 Global Dermatology Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Dermatology Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Dermatology Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Dermatology Drug Estimates and Projections (2016-2027)
2.4.2 Europe Dermatology Drug Estimates and Projections (2016-2027)
2.4.3 China Dermatology Drug Estimates and Projections (2016-2027)
2.4.4 Japan Dermatology Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Dermatology Drug Estimates and Projections (2016-2027)
2.4.6 India Dermatology Drug Estimates and Projections (2016-2027)
3 Global Dermatology Drug Competition Landscape by Players
3.1 Global Top Dermatology Drug Players by Sales (2016-2021)
3.2 Global Top Dermatology Drug Players by Revenue (2016-2021)
3.3 Global Dermatology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology Drug as of 2020)
3.4 Global Dermatology Drug Average Price by Company (2016-2021)
3.5 Manufacturers Dermatology Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Dermatology Drug Market Size by Type
4.1 Global Dermatology Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Dermatology Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Dermatology Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Dermatology Drug Price by Type (2016-2021)
4.2 Global Dermatology Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Dermatology Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Dermatology Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Dermatology Drug Price Forecast by Type (2022-2027)
5 Global Dermatology Drug Market Size by Application
5.1 Global Dermatology Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Dermatology Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Dermatology Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Dermatology Drug Price by Application (2016-2021)
5.2 Global Dermatology Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Dermatology Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Dermatology Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Dermatology Drug Price Forecast by Application (2022-2027)
6 North America Dermatology Drug Market Facts & Figures
6.1 North America Dermatology Drug Sales by Company
6.1.1 North America Dermatology Drug Sales by Company (2016-2021)
6.1.2 North America Dermatology Drug Revenue by Company (2016-2021)
6.2 North America Dermatology Drug Sales Breakdown by Type
6.2.1 North America Dermatology Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Dermatology Drug Sales Breakdown by Type (2022-2027)
6.3 North America Dermatology Drug Sales Breakdown by Application
6.3.1 North America Dermatology Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Dermatology Drug Sales Breakdown by Application (2022-2027)
7 Europe Dermatology Drug Market Facts & Figures
7.1 Europe Dermatology Drug Sales by Company
7.1.1 Europe Dermatology Drug Sales by Company (2016-2021)
7.1.2 Europe Dermatology Drug Revenue by Company (2016-2021)
7.2 Europe Dermatology Drug Sales Breakdown by Type
7.2.1 Europe Dermatology Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Dermatology Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Dermatology Drug Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Dermatology Drug Market Facts & Figures
8.1 China Dermatology Drug Sales by Company
8.1.1 China Dermatology Drug Sales by Company (2016-2021)
8.1.2 China Dermatology Drug Revenue by Company (2016-2021)
8.2 China Dermatology Drug Sales Breakdown by Type
8.2.1 China Dermatology Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Dermatology Drug Sales Breakdown by Type (2022-2027)
8.3 China Dermatology Drug Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Dermatology Drug Market Facts & Figures
9.1 Japan Dermatology Drug Sales by Company
9.1.1 Japan Dermatology Drug Sales by Company (2016-2021)
9.1.2 Japan Dermatology Drug Revenue by Company (2016-2021)
9.2 Japan Dermatology Drug Sales Breakdown by Type
9.2.1 Japan Dermatology Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Dermatology Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Dermatology Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Dermatology Drug Market Facts & Figures
10.1 Southeast Asia Dermatology Drug Sales by Company
10.1.1 Southeast Asia Dermatology Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Dermatology Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Dermatology Drug Sales Breakdown by Type
10.2.1 Southeast Asia Dermatology Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Dermatology Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Dermatology Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Dermatology Drug Market Facts & Figures
11.1 India Dermatology Drug Sales by Company
11.1.1 India Dermatology Drug Sales by Company (2016-2021)
11.1.2 India Dermatology Drug Revenue by Company (2016-2021)
11.2 India Dermatology Drug Sales Breakdown by Type
11.2.1 India Dermatology Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Dermatology Drug Sales Breakdown by Type (2022-2027)
11.3 India Dermatology Drug Sales Breakdown by Application
11.3.1 India Dermatology Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Dermatology Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Dermatology Drug Business
12.1 AbbVie
12.1.1 AbbVie Corporation Information
12.1.2 AbbVie Business Overview
12.1.3 AbbVie Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AbbVie Dermatology Drug Products Offered
12.1.5 AbbVie Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Dermatology Drug Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Dermatology Drug Products Offered
12.3.5 Bayer Recent Development
12.4 Galderma
12.4.1 Galderma Corporation Information
12.4.2 Galderma Business Overview
12.4.3 Galderma Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Galderma Dermatology Drug Products Offered
12.4.5 Galderma Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Corporation Information
12.5.2 Bristol-Myers Squibb Business Overview
12.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bristol-Myers Squibb Dermatology Drug Products Offered
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Dermatology Drug Products Offered
12.6.5 Novartis Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Dermatology Drug Products Offered
12.7.5 Pfizer Recent Development
12.8 Merz Pharma
12.8.1 Merz Pharma Corporation Information
12.8.2 Merz Pharma Business Overview
12.8.3 Merz Pharma Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merz Pharma Dermatology Drug Products Offered
12.8.5 Merz Pharma Recent Development
12.9 Valeant
12.9.1 Valeant Corporation Information
12.9.2 Valeant Business Overview
12.9.3 Valeant Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Valeant Dermatology Drug Products Offered
12.9.5 Valeant Recent Development
12.10 LEO Pharma
12.10.1 LEO Pharma Corporation Information
12.10.2 LEO Pharma Business Overview
12.10.3 LEO Pharma Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 LEO Pharma Dermatology Drug Products Offered
12.10.5 LEO Pharma Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Business Overview
12.11.3 GlaxoSmithKline Dermatology Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline Dermatology Drug Products Offered
12.11.5 GlaxoSmithKline Recent Development
13 Dermatology Drug Manufacturing Cost Analysis
13.1 Dermatology Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dermatology Drug
13.4 Dermatology Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dermatology Drug Distributors List
14.3 Dermatology Drug Customers
15 Market Dynamics
15.1 Dermatology Drug Market Trends
15.2 Dermatology Drug Drivers
15.3 Dermatology Drug Market Challenges
15.4 Dermatology Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dermatology Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Dermatology Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Dermatology Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Dermatology Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Dermatology Drug Sales Market Share by Region (2016-2021)
Table 6. Global Dermatology Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Dermatology Drug Revenue Share by Region (2016-2021)
Table 8. Global Dermatology Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Dermatology Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Dermatology Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Dermatology Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Dermatology Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Dermatology Drug Sales Share by Company (2016-2021)
Table 14. Global Dermatology Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Dermatology Drug Revenue Share by Company (2016-2021)
Table 16. Global Dermatology Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology Drug as of 2020)
Table 17. Global Dermatology Drug Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Dermatology Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Dermatology Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Dermatology Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Dermatology Drug Sales Share by Type (2016-2021)
Table 23. Global Dermatology Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Dermatology Drug Price (USD/Unit) by Type (2016-2021)
Table 25. Global Dermatology Drug Sales Share by Type (2022-2027)
Table 26. Global Dermatology Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Dermatology Drug Revenue Share by Type (2022-2027)
Table 28. Global Dermatology Drug Price (USD/Unit) by Type (2022-2027)
Table 29. Global Dermatology Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Dermatology Drug Sales Share by Application (2016-2021)
Table 31. Global Dermatology Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Dermatology Drug Price (USD/Unit) by Application (2016-2021)
Table 33. Global Dermatology Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Dermatology Drug Sales Share by Application (2022-2027)
Table 35. Global Dermatology Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Dermatology Drug Revenue Share by Application (2022-2027)
Table 37. Global Dermatology Drug Price (USD/Unit) by Application (2022-2027)
Table 38. North America Dermatology Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Dermatology Drug Sales Market Share by Company (2016-2021)
Table 40. North America Dermatology Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Dermatology Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Dermatology Drug Sales Market Share by Type (2016-2021)
Table 44. North America Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Dermatology Drug Sales Market Share by Type (2022-2027)
Table 46. North America Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Dermatology Drug Sales Market Share by Application (2016-2021)
Table 48. North America Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Dermatology Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Dermatology Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Dermatology Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Dermatology Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Dermatology Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Dermatology Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Dermatology Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Dermatology Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Dermatology Drug Sales Market Share by Application (2022-2027)
Table 62. China Dermatology Drug Sales (K Units) by Company (2016-2021)
Table 63. China Dermatology Drug Sales Market Share by Company (2016-2021)
Table 64. China Dermatology Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Dermatology Drug Revenue Market Share by Company (2016-2021)
Table 66. China Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Dermatology Drug Sales Market Share by Type (2016-2021)
Table 68. China Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Dermatology Drug Sales Market Share by Type (2022-2027)
Table 70. China Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Dermatology Drug Sales Market Share by Application (2016-2021)
Table 72. China Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Dermatology Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Dermatology Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Dermatology Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Dermatology Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Dermatology Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Dermatology Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Dermatology Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Dermatology Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Dermatology Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Dermatology Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Dermatology Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Dermatology Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Dermatology Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Dermatology Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Dermatology Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Dermatology Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Dermatology Drug Sales Market Share by Application (2022-2027)
Table 98. India Dermatology Drug Sales (K Units) by Company (2016-2021)
Table 99. India Dermatology Drug Sales Market Share by Company (2016-2021)
Table 100. India Dermatology Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Dermatology Drug Revenue Market Share by Company (2016-2021)
Table 102. India Dermatology Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Dermatology Drug Sales Market Share by Type (2016-2021)
Table 104. India Dermatology Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Dermatology Drug Sales Market Share by Type (2022-2027)
Table 106. India Dermatology Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Dermatology Drug Sales Market Share by Application (2016-2021)
Table 108. India Dermatology Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Dermatology Drug Sales Market Share by Application (2022-2027)
Table 110. AbbVie Corporation Information
Table 111. AbbVie Description and Business Overview
Table 112. AbbVie Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. AbbVie Dermatology Drug Product
Table 114. AbbVie Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Dermatology Drug Product
Table 119. Johnson & Johnson Recent Development
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Business Overview
Table 122. Bayer Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Bayer Dermatology Drug Product
Table 124. Bayer Recent Development
Table 125. Galderma Corporation Information
Table 126. Galderma Description and Business Overview
Table 127. Galderma Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Galderma Dermatology Drug Product
Table 129. Galderma Recent Development
Table 130. Bristol-Myers Squibb Corporation Information
Table 131. Bristol-Myers Squibb Description and Business Overview
Table 132. Bristol-Myers Squibb Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Bristol-Myers Squibb Dermatology Drug Product
Table 134. Bristol-Myers Squibb Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Novartis Dermatology Drug Product
Table 139. Novartis Recent Development
Table 140. Pfizer Corporation Information
Table 141. Pfizer Description and Business Overview
Table 142. Pfizer Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Pfizer Dermatology Drug Product
Table 144. Pfizer Recent Development
Table 145. Merz Pharma Corporation Information
Table 146. Merz Pharma Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Merz Pharma Description and Business Overview
Table 148. Merz Pharma Dermatology Drug Product
Table 149. Merz Pharma Recent Development
Table 150. Valeant Corporation Information
Table 151. Valeant Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Valeant Description and Business Overview
Table 153. Valeant Dermatology Drug Product
Table 154. Valeant Recent Development
Table 155. LEO Pharma Corporation Information
Table 156. LEO Pharma Description and Business Overview
Table 157. LEO Pharma Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. LEO Pharma Dermatology Drug Product
Table 159. LEO Pharma Recent Development
Table 160. GlaxoSmithKline Corporation Information
Table 161. GlaxoSmithKline Description and Business Overview
Table 162. GlaxoSmithKline Dermatology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. GlaxoSmithKline Dermatology Drug Product
Table 164. GlaxoSmithKline Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Dermatology Drug Distributors List
Table 168. Dermatology Drug Customers List
Table 169. Dermatology Drug Market Trends
Table 170. Dermatology Drug Market Drivers
Table 171. Dermatology Drug Market Challenges
Table 172. Dermatology Drug Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatology Drug Product Picture
Figure 2. Global Dermatology Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dermatology Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Psoriasis Examples
Figure 7. Skin Infections Examples
Figure 8. Acne Examples
Figure 9. Dermatitis Examples
Figure 10. Others Examples
Figure 11. Global Dermatology Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dermatology Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Dermatology Drug Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global Dermatology Drug Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Dermatology Drug Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Dermatology Drug Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Dermatology Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Dermatology Drug Sales (K Units) Growth Rate (2016-2027)
Figure 19. Europe Dermatology Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Dermatology Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Dermatology Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Dermatology Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Dermatology Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Dermatology Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Dermatology Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Dermatology Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Dermatology Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Dermatology Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Dermatology Drug Players Market Share by Revenue in Dermatology Drug: 2016 & 2020
Figure 30. Dermatology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Dermatology Drug Revenue Share by Type (2016-2021)
Figure 32. Global Dermatology Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Dermatology Drug Revenue Share by Application (2016-2021)
Figure 34. Global Dermatology Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Dermatology Drug Sales Market Share by Type in 2020
Figure 36. North America Dermatology Drug Sales Market Share by Application in 2020
Figure 37. Europe Dermatology Drug Sales Market Share by Type in 2020
Figure 38. Europe Dermatology Drug Sales Market Share by Application in 2020
Figure 39. China Dermatology Drug Sales Market Share by Type in 2020
Figure 40. China Dermatology Drug Sales Market Share by Application in 2020
Figure 41. Japan Dermatology Drug Sales Market Share by Type in 2020
Figure 42. Japan Dermatology Drug Sales Market Share by Application in 2020
Figure 43. Southeast Asia Dermatology Drug Sales Market Share by Type in 2020
Figure 44. Southeast Asia Dermatology Drug Sales Market Share by Application in 2020
Figure 45. India Dermatology Drug Sales Market Share by Type in 2020
Figure 46. India Dermatology Drug Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Dermatology Drug
Figure 49. Manufacturing Process Analysis of Dermatology Drug
Figure 50. Dermatology Drug Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
世界の皮膚科OTC用医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Dermatology OTC Drug Market The global Dermatology OTC Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…- 世界の皮膚科処方薬市場規模・現状・予測（2021年-2027年） Based on product types,the psoriasis drugs segment dominated the global market prescription dermatology therapeutics in 2017. Market Analysis and Insights: Global Prescription Dermatology Therapeutics Market The global Prescription Dermatology Therapeutics market size is projected to reach US$ 40000…
- 皮膚科用レーザーのグローバル市場2021 Dermatology Lasers is a kind of dermatology devices. Our report mainly covers the following product types by laser: Gas Laser Machine, Semiconductor Laser Machine and Gem Laser Machine. Market Analysis and Insights: Global Dermatology Laser Market The global Dermatology Laser market was valued at US…
- 世界の皮膚科におけるオゾン療法市場規模・現状・予測（2021年-2027年） Ozone therapy is a form of alternative medicine that purports to increase the amount of oxygen in the body through the introduction of ozone. Market Analysis and Insights: Global Ozone Therapy in Dermatology Market The global Ozone Therapy in Dermatology market size is projected to reach US$ 293.1 m…
- 皮膚科診断装置のグローバル市場2021 Dermatology Diagnostic Devices are designed for evaluating skin lesions suspected of malignancy. Dermatology Diagnostics Devices is mainly used in Skin Cancer, Psoriasis, Acne and Others, and in the next five years, the global consumption of Dermatology Diagnostics Devices will maintain more than 6%…